The DOI matches its Crossref record.
4‐n‐butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation
Abstract
Background Hyperpigmentary disorders like melasma, actinic and senile lentigines are a major cosmetic concern. Therefore, many topical products are available, containing various active ingredients aiming to reduce melanin production and distribution. The most prominent target for inhibitors of hyperpigmentation is tyrosinase, the key regulator of melanin production. Many inhibitors of tyrosinase are described in the literature; however, most of them lack clinical efficacy. Methods We were interested in evaluating the inhibition of skin pigmentation by well‐known compounds with skin‐whitening activity like hydroquinone, arbutin, kojic acid and 4‐n‐butylresorcinol. We compared the inhibition of human tyrosinase activity in a biochemical assay as well as inhibition of melanin production in MelanoDerm™ skin model culture. For some compounds, the in vivo efficacy was tested in clinical studies. Results Arbutin and hydroquinone only weakly inhibit human tyrosinase with a half maximal inhibitory concentration (IC 50) in the millimolar range. Kojic acid is 10 times more potent with an IC 50 of approximately 500 μmol/L. However, by far the most potent inhibitor of human tyrosinase is 4‐n‐butylresorcinol with an IC 50 of 21 μmol/L. In artificial skin models, arbutin was least active with an IC 50 for inhibition of melanin production > 5000 μmol/L. Kojic acid inhibited with an IC 50 > 400 μmol/L. Interestingly, hydroquinone inhibited melanin production in MelanoDerms with an IC 50 below 40 μmol/L, probably due to a mechanism different from tyrosinase inhibition. Again, 4‐n‐butylresorcinol was the most potent inhibitor with an IC 50 of 13.5 μmol/L. In vivo efficacy of 4‐n‐butyl‐resorcinol was confirmed in clinical studies. Subjects with age spots on the forearm treated twice daily two age spots with a formula containing 4‐n‐butylresorcinol and two control age spots with the corresponding vehicle. Within 8 weeks, 4‐n‐butylresorcinol reduced visibly the appearance of age spots, while the control spots showed no improvement. A second study showed that 4‐butylresorcinol was more effective than 4‐hexylresorcinol and 4‐phenylethylresorcinol. Conclusion The present in vitro and in vivo data prove the high inhibitory capacity of 4‐n‐butylresorcinol on human tyrosinase activity, exceeding by far the potency of hydroquinone, arbutin and kojic acid. The resulting clinical improvement of skin hyperpigmentations reveals 4‐n‐butylresorcinol as a very valuable active compound for the management of pigmentation disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
A comprehensive review on tyrosinase inhibitors
Zolghadri, S., Bahrami, A., Hassan Khan, M. T., Munoz-Munoz, J., Garcia-Molina, F., Garcia-Canovas, F., & Saboury, A. A. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1545767 · Cited by 1,078
Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors
Pillaiyar, T., Manickam, M., & Namasivayam, V. (2017) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2016.1256882 · Cited by 928
Natural, semisynthetic and synthetic tyrosinase inhibitors
Lee, S. Y., Baek, N., & Nam, T.-G. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2015.1004058 · Cited by 293
Targeting Metalloenzymes for Therapeutic Intervention
Chen, A. Y., Adamek, R. N., Dick, B. L., Credille, C. V., Morrison, C. N., & Cohen, S. M. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00201 · Cited by 270
Mann, T., Gerwat, W., Batzer, J., Eggers, K., Scherner, C., Wenck, H., Stäb, F., Hearing, V. J., Röhm, K.-H., & Kolbe, L. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.01.019 · Cited by 259
Self-citation
Metadata
- Authors
- Kolbe, L., Mann, T., Gerwat, W., Batzer, J., Ahlheit, S., Scherner, C., Wenck, H., & Stäb, F.
- Venue
- Journal of the European Academy of Dermatology and Venereology
- Publisher
- Wiley
- Published
- 2012-12-03
- Volume
- 27
- Issue
- s1
- Pages
- 19-23
- ISSN
- 0926-9959 (ISSN-L)
- 1468-3083
- OpenAlex
- W1550461747
- Cited by
- 173
- References
- 0
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 4‐n‐butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation. https://app.cochat.ai/papers/10.1111/jdv.12051
- The paper
- Kolbe, L., Mann, T., Gerwat, W., Batzer, J., Ahlheit, S., Scherner, C., Wenck, H., & Stäb, F. (2013). 4‐n‐butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.12051
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.